China Pharma Holdings (CPHI) Quarterly EPS earnings growth

chinapharmaholdings.com - graphic logo of issuer CPHI

China Pharma Holdings (CPHI) relies on the production of generics and dietary supplements to optimize costs by 2026. The brand's key authority is based on creating affordable treatments for psychoneurological pathologies, while on GURU.Markets, this line chart showing the quarterly EPS trajectory confirms a trend where the value of 78.30 characterizes this level. Additionally, the company is expanding its product range with antibiotics and cardiology drugs.

China Pharma Holdings, Inc. (CPHI) - Year-over-year earnings per one share growth for the last 12 months from 07/04/2022 to 11/18/2026

Analytical breakdowns and data insights for company chinapharmaholdings.com (CPHI)

- share price and consensus valuation forecast:
Summary company analytics:China Pharma Holdings, Inc. - CPHI
Flagship merchandise of China Pharma Holdings

This indicator measures quarterly net income per share dynamics, allowing for an assessment of the speed of capital recovery and the issuer's operational resilience during periods of volatility. By analyzing the quarterly EPS comparison, an investor can see the effectiveness of China Pharma Holdings (CPHI) expansion into the branded generics and B2B distribution segments, where sharp spikes in the curve confirm successful market share capture but necessitate caution when buying at local peaks.

Competitors of China Pharma Holdings (CPHI)

ALKS (alkermes.com) - Year-over-year net earnings per share growth for the last 12 months|Earnings per share growth in annualized terms for the last twelve months Avadel Pharma (AVDL)|ATAI (atai.life) - Quarterly EPS earnings growth|Year-over-year net earnings per share growth for the last 12 months GH Research PLC (GHRS)|Quarterly EPS earnings growth MNMD|CMPS (COMPASS Pathways PLC) - Year-over-year earnings per one share growth for the last 12 months|Year-over-year earnings per share growth for the last twelve months lbpharma.us LBRX|Bright Minds Biosciences Inc (DRUG) - Earnings per share growth in annualized terms for the last twelve months|VNDA: Year-over-year net earnings per share growth for the last 12 months|Cybin Inc (CYBN) - Year-over-year net earnings per share growth for the last 12 months|Alto Neuroscience (ANRO) - Year-over-year earnings per share growth for the last twelve months|NRx Pharma - Year-over-year earnings per one share growth for the last 12 months|Year-over-year earnings per share growth for the last twelve months Cingulate|Year-over-year earnings per share growth for the last twelve months SILO|Quarterly EPS earnings growth CMND|Psyence Biomedical Ltd. - Year-over-year earnings per share growth for the last 12 months|Year-over-year earnings per share growth for the last twelve months SciSparc Ltd SPRC|Seelos Therapeutics Inc. (SEEL) - Earnings per share growth in annualized terms for the last twelve months|VRPX: Year-over-year net earnings per share growth for the last 12 months|KRTX - Quarterly EPS earnings growth